Thrift Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 07-07-2024
- Paid Up Capital ₹ 3.00 M
as on 07-07-2024
- Company Age 28 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.00 M
as on 07-07-2024
- Satisfied Charges ₹ 5.00 M
as on 07-07-2024
- Revenue -11.12%
(FY 2021)
- Profit 244.49%
(FY 2021)
- Ebitda 68.45%
(FY 2021)
- Net Worth 26.82%
(FY 2021)
- Total Assets -9.35%
(FY 2021)
About Thrift Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹4.00 M. The company has closed loans amounting to ₹5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Meenu Singh, Manav Singh, and Jagminder Singh serve as directors at the Company.
- CIN/LLPIN
U24231GJ1996PTC030237
- Company No.
030237
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jul 1996
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- LocationBaroda, Gujarat
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Thrift Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Meenu Singh  | Director | 15-Feb-2022 | Current |
| Manav Singh | Director | 15-May-2013 | Current |
| Jagminder Singh | Director | 01-Aug-1996 | Current |
Financial Performance of Thrift Pharmaceuticals.
Thrift Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 11.12% decrease. The company also saw a substantial improvement in profitability, with a 244.49% increase in profit. The company's net worth Soared by an impressive increase of 26.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Thrift Pharmaceuticals?
In 2021, Thrift Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Cavendish Bio Pharma Private LimitedActive 19 years 3 monthsManav Singh and Jagminder Singh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 13 Mar 2015 | ₹4.00 M | Open |
Punjab National Bank Creation Date: 12 Jun 2013 | ₹5.00 M | Satisfied |
How Many Employees Work at Thrift Pharmaceuticals?
Thrift Pharmaceuticals has a workforce of 42 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Thrift Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Thrift Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
